Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02047500 |
|---|---|
| Brief Title: | Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer |
| First Submitted : | January 24, 2014 |
| First Submitted that Met QC Criteria : | January 24, 2014 |
| First Posted : | January 28, 2014 (Estimate) |
| Results First Submitted : | July 18, 2017 |
| Results First Submitted that Met QC Criteria : | July 18, 2017 |
| Results First Posted : | December 15, 2017 |
| Last Update Submitted that Met QC Criteria : | July 18, 2017 |
| Last Update Posted : | December 15, 2017 |